BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell differentiation
,
Inflammatory disorder
,
Hippocampus
,
Nosology
,
Tamoxifen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SOCS-3
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Lung
Omental adipose tissue
Vena cava
Bronchus
Trachea
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Suppression of SOCS3 expression in macrophage cells: Potential application in diabetic wound healing…
Prmt7 regulates the JAK/STAT/Socs3 signaling pathway in postmenopausal cardiomyopathy.
Silencing suppressor of cytokine signaling 3 induces apoptosis and activates the p-STAT3/NF-κB pathw…
AMPK-autophagy-mediated inhibition of microRNA-30a-5p alleviates morphine tolerance via SOCS3-depend…
Suppressor of cytokine signalling 3 (SOCS3) expressed in podocytes attenuates glomerulonephritis and…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)
A Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (S…
Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Part…
Clinical Study Of Affinity Versus SOC In The Management Of VLUs
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ